Профиль Newron Pharmaceuticals S.p.A.Az.
Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focus on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago for Parkinson's disease; sarizotan for patients with Rett syndrome and ralfinamide for patients with rare pain indications. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.